Safe Injection Sites and Needle Exchange Programs: An Important Part of Ensuring Health to Injection Drug Users
DOI:
https://doi.org/10.18192/riss-ijhs.v1i1.1530Keywords:
N/AAbstract
N/AReferences
Andresen, M. A., & Boyd, N. (2009). A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility. Int J Drug Policy, 21(1), 70-76.doi: 10.1016/ j.drugpo.2009.03.004
Ball, A. L. (2007). HIV, injecting drug use and harm reduction: a public health response. Addiction, 102(5), 684-90
Bayoumi, A. M., & Zaric, G. S. (2008). The cost-effectiveness of Vancouver's supervised injection facility. CMAJ, 179(11), 1143-51. doi: 10.1503/cmaj.08080
Burris, S., Lurie, P., Abrahamson, D., & Rich, J. D. (2000). Canadian Medical Association’s 141st annual general council - Physician Prescribing of Sterile Injection Equipment To Prevent HIV Infection: Time for Action. Annals of Internal Medicine, 133(3), 218-226. doi: 10.7326/0003-4819 -133-3-200008010-00015
Carrieri, M. P., & Spire B. (2008). Harm reduction and control of HIV in IDUs in France. Lancet, 372(9637), 448. doi: 10.1016/S0140-6736(08)61195-2
Collier, R. (2008). Clement unleashes barrage at safe injection site supporters. CMAJ, [Epub ahead of print], PMID: 18713814, retrieved from PubMed doi: 10.1503/ cmaj.081305
Discussion Forum: Supervised Injection Site Evaluative Research. (2009). Canadian Centre on Substance Abuse. Retrieved from http://www.ccsa.ca/2009%20CCSA%20Documents/ccsa0117852009_e.pdf
Freeman, K., Jones, C. G., Weatherburn, D. J., Rutter, S., Spooner, C. J., & Donnelly, N. (2005). The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime. Drug Alcohol Review, 24(2), 173-84. doi: 10.1080/09595230500167460
Garmaise, D. (2005). Officials in two Canadian cities express support for safe injection sites. HIV/AIDS policy & law review/Canadian HIV/AIDS Legal Network, 10(2), 21-2.
Health Canada releases report on supervised injection facility. (2008). HIV AIDS Policy Law Rev, 13(1), 31-32.
Holtzman, D., Barry, V., Ouellet, L. J., Des Jarlais, D. C., Vlahov, D., Golub, E. T., ... Garfein, R. S. (2009). The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994 -2004. Prev Med., 49(1), 68-73. doi: 10.1016/ j.ypmed.2009.04.014
Kerr, T., Oleson, M., & Wood, E. (2004). Harm-reduction activism: a case study of an unsanctioned user-run safe injection site. Can HIV AIDS Policy Law Rev., 8(3), 142- 143.
Kleinig, J. (2006). Thinking ethically about needle and syringe programs. Subst Use Misuse., 41(6-7), 815-25. doi: 10.1080/10826080600668670
Legal Status of Insite. Vancouver Coastal Health. (2009).
O’Connor, E. (July 7, 2009). Insite drug-injection facility awaits fate amid controversy. The Province. Retrieved from http://www.theprovince.com/health/Insite+drug+injection+facility+awaits+fate+amid+controv ersy/1767204/story.html
Salmon, A. M., Thein, H. H., Kimber, J., Kaldor, J. M., & Maher, L. (2007). Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre? National Int J Drug Policy, 18(1), 46-53. Retrieved from http://dx.doi.org/10.1016/ j.drugpo.2006.11.010
State of the Knowledge: Needle Exchange Programs. BC Partners for Mental Health and Addictions Information. Retrieved from www.upnbc.org/needleexchange.pdf
Tyndall, M. W., Kerr, T., Zhang, R., King, E., Montaner, J. G., & Wood, E. (2006). Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. Drug Alcohol Depend., 83(3),193-8. Retrieved from http://dx.doi.org/10.1016/j.drugalcdep.2005.11.011
Tyndall, M. W., Currie, S., Spittal, P., Li, K., Wood, E., O'Shaughnessy, M. V., & Schechter, M. T. (2003) Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS, 17(6), 887-93. doi: 10.1097/01.aids.0000050859.71999.ae
Voth, E. A. (2008). Harm reduction drug policy. Lancet Infect Dis., 8(3), 142-3. Retrieved from http:// dx.doi.org/10.1016/S1473-3099(08)70189-0
Wood, E., Tyndall, M. W., Lai, C., Montaner, J. S, & Kerr, T. (2006). Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Subst Abuse Treat Prev Policy, 8(1), 13. doi: 10.1186/1747- 597X-1-13
Wynia, M. K. (2005). Science, Faith and AIDS: The Battle Over Harm Reduction. The American Journal of Bioethics, 5(2), 3-4. doi: 10.1080/15265160590961699
Weatherburn, D. (2009). Dilemmas in Harm Minimization. Addiction, 104(3), 335-339. doi: 10.1111/j.1360- 0443.2008.02336.x
Ball, A. L. (2007). HIV, injecting drug use and harm reduction: a public health response. Addiction, 102(5), 684-90
Bayoumi, A. M., & Zaric, G. S. (2008). The cost-effectiveness of Vancouver's supervised injection facility. CMAJ, 179(11), 1143-51. doi: 10.1503/cmaj.08080
Burris, S., Lurie, P., Abrahamson, D., & Rich, J. D. (2000). Canadian Medical Association’s 141st annual general council - Physician Prescribing of Sterile Injection Equipment To Prevent HIV Infection: Time for Action. Annals of Internal Medicine, 133(3), 218-226. doi: 10.7326/0003-4819 -133-3-200008010-00015
Carrieri, M. P., & Spire B. (2008). Harm reduction and control of HIV in IDUs in France. Lancet, 372(9637), 448. doi: 10.1016/S0140-6736(08)61195-2
Collier, R. (2008). Clement unleashes barrage at safe injection site supporters. CMAJ, [Epub ahead of print], PMID: 18713814, retrieved from PubMed doi: 10.1503/ cmaj.081305
Discussion Forum: Supervised Injection Site Evaluative Research. (2009). Canadian Centre on Substance Abuse. Retrieved from http://www.ccsa.ca/2009%20CCSA%20Documents/ccsa0117852009_e.pdf
Freeman, K., Jones, C. G., Weatherburn, D. J., Rutter, S., Spooner, C. J., & Donnelly, N. (2005). The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime. Drug Alcohol Review, 24(2), 173-84. doi: 10.1080/09595230500167460
Garmaise, D. (2005). Officials in two Canadian cities express support for safe injection sites. HIV/AIDS policy & law review/Canadian HIV/AIDS Legal Network, 10(2), 21-2.
Health Canada releases report on supervised injection facility. (2008). HIV AIDS Policy Law Rev, 13(1), 31-32.
Holtzman, D., Barry, V., Ouellet, L. J., Des Jarlais, D. C., Vlahov, D., Golub, E. T., ... Garfein, R. S. (2009). The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994 -2004. Prev Med., 49(1), 68-73. doi: 10.1016/ j.ypmed.2009.04.014
Kerr, T., Oleson, M., & Wood, E. (2004). Harm-reduction activism: a case study of an unsanctioned user-run safe injection site. Can HIV AIDS Policy Law Rev., 8(3), 142- 143.
Kleinig, J. (2006). Thinking ethically about needle and syringe programs. Subst Use Misuse., 41(6-7), 815-25. doi: 10.1080/10826080600668670
Legal Status of Insite. Vancouver Coastal Health. (2009).
O’Connor, E. (July 7, 2009). Insite drug-injection facility awaits fate amid controversy. The Province. Retrieved from http://www.theprovince.com/health/Insite+drug+injection+facility+awaits+fate+amid+controv ersy/1767204/story.html
Salmon, A. M., Thein, H. H., Kimber, J., Kaldor, J. M., & Maher, L. (2007). Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre? National Int J Drug Policy, 18(1), 46-53. Retrieved from http://dx.doi.org/10.1016/ j.drugpo.2006.11.010
State of the Knowledge: Needle Exchange Programs. BC Partners for Mental Health and Addictions Information. Retrieved from www.upnbc.org/needleexchange.pdf
Tyndall, M. W., Kerr, T., Zhang, R., King, E., Montaner, J. G., & Wood, E. (2006). Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. Drug Alcohol Depend., 83(3),193-8. Retrieved from http://dx.doi.org/10.1016/j.drugalcdep.2005.11.011
Tyndall, M. W., Currie, S., Spittal, P., Li, K., Wood, E., O'Shaughnessy, M. V., & Schechter, M. T. (2003) Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS, 17(6), 887-93. doi: 10.1097/01.aids.0000050859.71999.ae
Voth, E. A. (2008). Harm reduction drug policy. Lancet Infect Dis., 8(3), 142-3. Retrieved from http:// dx.doi.org/10.1016/S1473-3099(08)70189-0
Wood, E., Tyndall, M. W., Lai, C., Montaner, J. S, & Kerr, T. (2006). Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Subst Abuse Treat Prev Policy, 8(1), 13. doi: 10.1186/1747- 597X-1-13
Wynia, M. K. (2005). Science, Faith and AIDS: The Battle Over Harm Reduction. The American Journal of Bioethics, 5(2), 3-4. doi: 10.1080/15265160590961699
Weatherburn, D. (2009). Dilemmas in Harm Minimization. Addiction, 104(3), 335-339. doi: 10.1111/j.1360- 0443.2008.02336.x
Downloads
Published
2016-03-10
Issue
Section
Articles
License
- All authors published in the IJHS will retain copyright of their article.
- Authors grant the IJHS the right of first publication of their submitted articles.
- All articles published in the IJHS are licensed under a Creative Commons Attribution License that allows others to share articles if original authors and journal of initial publication are acknowledged.
- The IJHS is published online and in print, therefore the journal is not responsible for any unauthorized misuse of published content in either electronic or print form
- The IJHS retains the serial distribution rights to all contents
- It is the responsibility of the authors and not the IJHS to ensure proper permissions for all cited work have been obtained
